Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

SIGA Technologies Inc

+ Add to Watchlist

SIGA:US

1.4100 USD 0.0100 0.71%

As of 20:10:00 ET on 01/30/2015.

Snapshot for SIGA Technologies Inc (SIGA)

Open: 1.4000 Day's Range: 1.3900 - 1.4500 Volume: 87,712
Previous Close: 1.4000 52wk Range: 0.9901 - 3.5600 1-Yr Rtn: -57.40%

Stock Chart for SIGA

No chart data available.
  • SIGA:US 1.4100
  • 1D
  • 1M
  • 1Y
1.4000
Interactive SIGA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SIGA

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -2.5505
Est. EPS (USD) (12/2014) -
Est. PEG Ratio -
Market Cap (M USD) 75.44
Shares Outstanding (M) 53.50
30 Day Average Volume 140,470
Price/Book (mrq) -
Price/Sale (ttm) 23.2397
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/10/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SIGA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for SIGA

SIGA Technologies, Inc. explores, develops, and markets products for use in defense against biological warfare agents. The Company's also offers products such as novel anti-infectives or the prevention and treatment of serious infectious diseases.

Eric A RoseChairman/CEODaniel J LuckshireExec VP/CFO/Secretary
William J HaynesExec VP/General CounselDennis E HrubyVP/Chief Scientific Officer
More Company Profile & Key Executives for SIGA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil